‹ All episodes

OIS Podcast | Ophthalmology's leading Podcast

Clearside Biomedical Finds the Public Markets Despite Diminished Interest in Sector

July 26, 2016 OIS
OIS Podcast | Ophthalmology's leading Podcast
Clearside Biomedical Finds the Public Markets Despite Diminished Interest in Sector
Info
OIS Podcast | Ophthalmology's leading Podcast
Clearside Biomedical Finds the Public Markets Despite Diminished Interest in Sector
Jul 26, 2016
OIS
Clearside CEO Dan White says the days when ophthalmology IPO candidates could do no wrong are over. Still, the company staged a successful IPO to help further development of its SCS microinjector technology.
Share
Apple Podcasts Spotify Amazon Music Overcast iHeartRadio Castro +
Show Notes
Clearside CEO Dan White says the days when ophthalmology IPO candidates could do no wrong are over. Still, the company staged a successful IPO to help further development of its SCS microinjector technology.